Ventura BioMed Investors

Ventura BioMed Investors specializes in financing early-stage life science companies throughout Europe. The firm provides capital, often within consortia, to ventures developing pioneering technologies and innovative therapies. Beyond funding, Ventura BioMed actively supports its portfolio with expert industry knowledge and network access, accelerating biomedical solution development.

The firm was founded by Dr. Andreas Jenne and Dr. Kurt Rudolf Schwarz, seasoned entrepreneurs with extensive biotech and pharmaceutical experience. Jenne has a strong record of company launches, while Schwarz contributes deep investment acumen and scientific expertise. Their insight was to merge strategic capital with profound industry knowledge, propelling nascent biomedical innovations.

Ventura BioMed primarily serves visionary entrepreneurs advancing medical frontiers. Its mission is to catalyze medical breakthroughs by nurturing these enterprises. Through targeted investment and active guidance, Ventura BioMed aims to shape the future of medicine, bringing novel diagnostics and therapies to address unmet patient needs.